Please find attached herewith Proceedings of the meeting of the equity shareholders of the Company and Scrutinizer''s Report on e-voting.

17th August, 2026 The Corporate Relationship Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Bandra East, Mumbai 400 001. Mumbai 400 051. Scrip Code: 539523 Scrip Symbol: ALKEM Ref: In the matter of scheme of amalgamation between Alkem Laboratories Limited (“Company”) and Adroit Biomed Limited (“ABL”) under Sections 230 to 232 read with other relevant provisions of the Companies Act, 2013 (“Scheme” or “Scheme of Amalgamation”). Sub: Proceedings of the meeting of the equity shareholders of the Company and Scrutinizer’s Report on e-voting (remote e-voting and e-voting at the Meeting) Dear Sir/Madam, We enclose herewith the following in connection with the meeting of the equity shareholders of the Company convened pursuant to the Order dated June 10, 2026, passed by the Hon’ble National Company Law Tribunal, Mumbai Bench and held on Monday, August 17, 2026: 1. Summary of the proceedings of the Meeting 2. Scrutinizer’s Report on e-voting (remote e-voting and e-voting at the Meeting). Sincerely, For Alkem Laboratories Limited Manish Narang President – Legal, Company Secretary & Compliance Officer Encl: a/a Summary of proceedings of the meeting of the equity shareholders of the Company convened pursuant to the Order of Hon’ble National Company Law Tribunal, Mumbai Bench (“NCLT Mumbai”) and held on Monday, August 17, 2026 (“Meeting”) A. Date, time and venue of the Meeting The Meeting of the equity shareholders of the Company convened pursuant to the Order dated June 10, 2026, passed by NCLT Mumbai was held on Monday, August 17, 2026 at 11:00 a.m. (IST) through video conferencing/other audio visual means (“VC/OAVM”). B. Proceedings in brief Mr. Harihar Prakash Chaturvedi, former Additional Secretary, Government of India, Ministry of Law and Justice and Judicial Member of the NCLT Mumbai, chaired the Meeting (“Chairperson”). The Chairperson called the Meeting to order and commenced at 11:15 a.m., the requisite quorum being present. The Chairperson thereafter stated that the Meeting was held through VC/OAVM in compliance with the directions of the Order of NCLT Mumbai dated June 10, 2026. The Chairperson thereafter addressed the equity shareholders. The equity shareholders were then informed that the remote e- voting commenced at 9:00 a.m. (IST) on Wednesday, August 12, 2026 and concluded at 5:00 p.m. (IST) on Sunday, August 16, 2026. Scheme of Amalgamation between Adroit Biomed Limited (“Transferor Company”) and Alkem Laboratories Limited (“Transferee Company”/ “Company”) (“Scheme”) was placed before the equity shareholders for consideration and approval. The Chairperson informed the equity shareholders that Mr. Ritul Parmar, a practicing Company Secretary, was appointed as the Scrutinizer to scrutinize the voting through electronic means (i.e., remote e-voting and voting at the Meeting by using electronic system) (“e-voting”). The Chairperson informed the equity shareholders that the results of e-voting shall be disseminated to the stock exchanges and also uploaded on the website of the Company and Central Depository Services (India) Limited, providing remote e-voting prior to the Meeting and e-voting during the Meeting through VC/OAVM. C. Voting by equity shareholders The Company had provided remote e-voting facility to its equity shareholders to cast votes electronically on the business set out in the Notice of the Meeting from 9:00 a.m. (IST) on Wednesday, August 12, 2026 to 5:00 p.m. (IST) on Sunday, August 16, 2026. Further, the facility to vote on the resolution through electronic voting system at the Meeting was made available to the equity shareholders who participated in the Meeting and had not cast their votes through remote e-voting. D. Results of e-voting (remote e-voting and e-voting at the Meeting) Votes in favour – 99.9999% Note: This document does not constitute the minutes of the proceedings of the Meeting of the Company. For Alkem Laboratories Limited Manish Narang President – Legal, Company Secretary & Compliance Officer Place: Mumbai Date: August 17, 2026 Hon’ble National Company Law Tribunal convened meeting of the equity shareholders of Alkem Laboratories Limited Date of Meeting : 17th August, 2026 Total number of shareholders on record date : 63667 No. of shareholders present in the meeting either in person or through proxy: Not Applicable Promoters and Promoter Group: 0 Public: 0 No. of shareholders attended the meeting through video conferencing (“VC”) / Other Audio Visual Means ("OAVM"): Promoters and Promoter Group: 5 Public: 32 Alkem Laboratories Limited 1 - Approval of the Scheme of amalgamation between Adroit Biomed Limited and Alkem Laboratories Resolution Required :Special Limited under Sections 230-232 and other applicable provisions of the Companies Act, 2013. Whether promoter/ promoter group are interested in the No agenda/resolution? No. of % of Votes Polled No. of % of Votes in Mode of Category No. of shares votes on outstanding No. of Votes Votes favour on votes % of Votes against Voting held polled shares – in favour –Against polled on votes polled E-Voting 56492801 95.0659 56492801 0 100.0000 0.0000 Promoter and Promoter Poll 0 0.0000 0 0 0.0000 0.0000 59424889 Group Postal Ballot 0 0.0000 0 0 0.0000 0.0000 Total 56492801 95.0659 56492801 0 100.0000 0.0000 E-Voting 37130858 93.7473 37130858 0 100.0000 0.0000 Poll 0 0.0000 0 0 0.0000 0.0000 Public Institutions 39607384 Postal Ballot 0 0.0000 0 0 0.0000 0.0000 Total 37130858 93.7473 37130858 0 100.0000 0.0000 E-Voting 6361637 30.9829 6361553 84 99.9987 0.0013 Poll 0 0.0000 0 0 0.0000 0.0000 Public Non Institutions 20532727 Postal Ballot 0 0.0000 0 0 0.0000 0.0000 Total 6361637 30.9829 6361553 84 99.9987 0.0013 Total 119565000 99985296 83.6242 99985212 84 99.9999 0.0001